Crinetics Pharmaceuticals CRNX Free cash flow margin

Free cash flow margin at other companies

Neurocrine BiosciencesNBIX

26.8%+6.4pp

Corcept TherapeuticsCORT

12.9%-12.3pp

BridgeBio PharmaBBIO

-76.8%—

Amylyx Pharmaceuticals, Inc.AMLX

-39,826.7%-39,847pp

Eton Pharmaceuticals, Inc.ETON

17.1%—

Amneal Pharmaceuticals, Inc.AMRX

4.1%-5.8pp

FAQ

What is Crinetics Pharmaceuticals's free cash flow margin?

Crinetics Pharmaceuticals (CRNX) reported free cash flow margin of -2,321.7% in Q1 2026.

How has Crinetics Pharmaceuticals's free cash flow margin changed year-over-year?

Crinetics Pharmaceuticals's free cash flow margin increased by 93.5% year-over-year, from -35,465.9% to -2,321.7%.

What is the long-term trend for Crinetics Pharmaceuticals's free cash flow margin?

Over 4 years (2021 to 2025), Crinetics Pharmaceuticals's free cash flow margin has grown at a -11.9% compound annual growth rate (CAGR), from -8,258.3% to -4,985.5%.

What does free cash flow margin mean?

Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.